Exercise Intolerance in Heart Failure With Preserved Ejection Fraction: Diagnosing and Ranking Its Causes Using Personalized O 2 Pathway Analysis

Heart failure with preserved ejection fraction (HFpEF) is a common syndrome with a pressing shortage of therapies. Exercise intolerance is a cardinal symptom of HFpEF, yet its pathophysiology remains uncertain. We investigated the mechanism of exercise intolerance in 134 patients referred for cardio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation (New York, N.Y.) N.Y.), 2018-01, Vol.137 (2), p.148-161
Hauptverfasser: Houstis, Nicholas E, Eisman, Aaron S, Pappagianopoulos, Paul P, Wooster, Luke, Bailey, Cole S, Wagner, Peter D, Lewis, Gregory D
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Heart failure with preserved ejection fraction (HFpEF) is a common syndrome with a pressing shortage of therapies. Exercise intolerance is a cardinal symptom of HFpEF, yet its pathophysiology remains uncertain. We investigated the mechanism of exercise intolerance in 134 patients referred for cardiopulmonary exercise testing: 79 with HFpEF and 55 controls. We performed cardiopulmonary exercise testing with invasive monitoring to measure hemodynamics, blood gases, and gas exchange during exercise. We used these measurements to quantify 6 steps of oxygen transport and utilization (the O pathway) in each patient with HFpEF, identifying the defective steps that impair each one's exercise capacity (peak Vo ). We then quantified the functional significance of each O pathway defect by calculating the improvement in exercise capacity a patient could expect from correcting the defect. Peak Vo was reduced by 34±2% (mean±SEM,
ISSN:0009-7322
1524-4539
DOI:10.1161/CIRCULATIONAHA.117.029058